Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-043341
Filing Date
2011-08-04
Accepted
2011-08-04 06:18:52
Documents
13
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-14083_110q.htm 10-Q 797863
2 EX-10.3 a11-14083_1ex10d3.htm EX-10.3 282690
3 EX-10.4 a11-14083_1ex10d4.htm EX-10.4 50598
4 EX-10.5 a11-14083_1ex10d5.htm EX-10.5 79898
5 EX-31.1 a11-14083_1ex31d1.htm EX-31.1 11918
6 EX-31.2 a11-14083_1ex31d2.htm EX-31.2 12853
7 EX-32.1 a11-14083_1ex32d1.htm EX-32.1 10293
  Complete submission text file 0001104659-11-043341.txt   3297120

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snta-20110630.xml EX-101.INS 367507
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20110630.xsd EX-101.SCH 13852
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20110630_cal.xml EX-101.CAL 33024
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20110630_lab.xml EX-101.LAB 213992
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20110630_pre.xml EX-101.PRE 100242
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20110630_def.xml EX-101.DEF 62607
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 111008587
SIC: 2834 Pharmaceutical Preparations